Table 6.
|
|
|
|
[No chemotherapy] |
[Had chemotherapy] |
||||
---|---|---|---|---|---|---|---|---|---|
|
Waited > 60 days |
Waited > 90 days |
Waited > 210 days |
||||||
|
diagnosis to surgery |
surgery to radiation therapy |
surgery to radiation therapy |
||||||
Predictor variables | Sample | OR | (95% CI) | Sample | OR | (95% CI) | Sample | OR | (95% CI) |
|
Single predictor models |
||||||||
Neighborhood poverty | |||||||||
< 5% poor |
1,975 |
1.00 |
|
640 |
1.00 |
|
403 |
1.00 |
|
5-29% poor |
1,901 |
1.21 |
(0.92, 1.59) |
507 |
1.06 |
(0.71, 1.57) |
382 |
0.84 |
(0.59, 1.18) |
≥ 30% poor |
1,841 |
1.88 |
(1.46, 2.43) |
382 |
1.50 |
(1.01, 2.25) |
361 |
0.89 |
(0.63, 1.26) |
Primary payer | |||||||||
Uninsured or Medicaid |
934 |
1.00 |
|
224 |
1.00 |
|
252 |
1.00 |
|
Medicare or private |
4,783 |
0.61 |
(0.48, 0.77) |
1,305 |
0.52 |
(0.35, 0.77) |
894 |
0.87 |
(0.62, 1.23) |
|
Full models |
||||||||
Neighborhood poverty | |||||||||
< 5% poor |
1,975 |
1.00 |
|
640 |
1.00 |
|
403 |
1.00 |
|
5-29% poor |
1,901 |
1.95* |
(0.94, 4.03) |
507 |
1.02 |
(0.69, 1.52) |
382 |
1.92 |
(1.02, 3.61) |
≥ 30% poor |
1,841 |
2.86 |
(1.40, 5.82) |
382 |
1.37 |
(0.91, 2.06) |
362 |
1.54 |
(0.83, 2.84) |
Primary payer | |||||||||
Uninsured or Medicaid |
934 |
1.00 |
|
224 |
1.00 |
|
252 |
1.00 |
|
Medicare or private |
4,783 |
1.13 |
(0.56, 2.29) |
1,305 |
0.55 |
(0.37, 0.82) |
894 |
0.65 |
(0.42, 1.00) |
Poverty by payer |
5,717 |
0.52* |
(0.25, 1.11) |
1,529 |
1.03a |
(0.64, 1.67) |
1,146 |
1.96* |
(0.97, 3.97) |
|
Poverty by payer interaction on surgical wait times of more than 2 months |
||||||||
|
|
> 5% poor |
|
< 5% poor |
|
||||
|
|
Sample |
OR |
(95% CI) |
|
Sample |
OR |
(95% CI) |
|
Primary payer | |||||||||
Uninsured or Medicaid |
|
765 |
1.00 |
|
|
169 |
1.00 |
|
|
Medicare or private |
|
2,977 |
0.58 |
(0.44, 0.75) |
|
1,806 |
1.18 |
(0.58, 2.39) |
|
|
Poverty by payer interaction among women who received chemotherapy on post-surgical wait times of more than 7 months for RT |
||||||||
|
|
> 30% poor |
|
< 30% poor |
|
||||
|
|
Sample |
OR |
(95% CI) |
|
Sample |
OR |
(95% CI) |
|
Primary payer | |||||||||
Uninsured or Medicaid |
|
121 |
1.00 |
|
|
131 |
1.00 |
|
|
Medicare or private | 240 | 0.96 | (0.59, 1.57) | 654 | 0.70* | (0.47, 1.03) |
Notes. OR = odds ratio, CI = confidence interval. All effects were age and stage-adjusted across these categories: 25–44, 45–54, 55–64, 65–74 and 75 or older; and node positive or node negative breast cancer. Bolded ORs were statistically significant at p < .05.
a Null interaction was removed from the full model. *p < 10.